Literature DB >> 24515801

The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.

Syng-Ook Lee1,2, Un-Ho Jin1, Jeong Han Kang3, Sang Bae Kim4, Aaron S Guthrie5, Sandeep Sreevalsan6, Ju-Seog Lee4, Stephen Safe1,6.   

Abstract

UNLABELLED: NR4A1 (Nur77, TR3) is an orphan nuclear receptor that is overexpressed in pancreatic cancer and exhibits pro-oncogenic activity. RNA interference of NR4A1 expression in Panc-1 cells induced apoptosis and subsequent proteomic analysis revealed the induction of several markers of endoplasmic reticulum stress, including glucose-related protein 78 (GRP78), CCAAT/enhancer-binding protein-homologous protein (CHOP), and activating transcription factor-4 (ATF-4). Treatment of pancreatic cancer cells with the NR4A1 antagonist 1,1-bis(3'-indolyl)-1-(p-hydroxyphenyl)methane (DIM-C-pPhOH) gave similar results. Moreover, both NR4A1 knockdown and DIM-C-pPhOH induced reactive oxygen species (ROS), and induction of ROS and endoplasmic reticulum stress by these agents was attenuated after cotreatment with antioxidants. Manipulation of NR4A1 expression coupled with gene expression profiling identified a number of ROS metabolism transcripts regulated by NR4A1. Knockdown of one of these transcripts, thioredoxin domain containing 5 (TXNDC5), recapitulated the elevated ROS and endoplasmic reticulum stress; thus, demonstrating that NR4A1 regulates levels of endoplasmic reticulum stress and ROS in pancreatic cancer cells to facilitate cell proliferation and survival. Finally, inactivation of NR4A1 by knockdown or DIM-C-pPhOH decreased TXNDC5, resulting in activation of the ROS/endoplasmic reticulum stress and proapoptotic pathways. IMPLICATIONS: The NR4A1 receptor is pro-oncogenic, regulates the ROS/endoplasmic reticulum stress pathways, and inactivation of the receptor represents a novel pathway for inducing cell death in pancreatic cancer. Mol Cancer Res; 12(4); 527-38. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515801      PMCID: PMC4407472          DOI: 10.1158/1541-7786.MCR-13-0567

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  45 in total

1.  Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells.

Authors:  Elena V Sheveleva; Terry H Landowski; Betty K Samulitis; Geoffrey Bartholomeusz; Garth Powis; Robert T Dorr
Journal:  Mol Cancer Res       Date:  2012-01-24       Impact factor: 5.852

2.  Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.

Authors:  A Brás; J P Albar; E Leonardo; G G de Buitrago; C Martínez-A
Journal:  Cell Death Differ       Date:  2000-03       Impact factor: 15.828

3.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 4.  Targeting Nur77 translocation.

Authors:  Xiao-kun Zhang
Journal:  Expert Opin Ther Targets       Date:  2007-01       Impact factor: 6.902

5.  Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.

Authors:  Syng-Ook Lee; Maen Abdelrahim; Kyungsil Yoon; Sudhakar Chintharlapalli; Sabitha Papineni; Kyounghyun Kim; Huamin Wang; Stephen Safe
Journal:  Cancer Res       Date:  2010-07-21       Impact factor: 12.701

6.  Identification of a novel thioredoxin-related protein, PC-TRP, which is preferentially expressed in plasma cells.

Authors:  Jens Wrammert; Eva Källberg; Tomas Leanderson
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

7.  EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor.

Authors:  Dianne C Sullivan; Lucasz Huminiecki; John W Moore; Joseph J Boyle; Richard Poulsom; Daniel Creamer; Jonathan Barker; Roy Bicknell
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

8.  Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells.

Authors:  Siva Kumar Kolluri; Nathalie Bruey-Sedano; Xihua Cao; Bingzhen Lin; Feng Lin; Young-Hoon Han; Marcia I Dawson; Xiao-kun Zhang
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

10.  The NR4A subgroup: immediate early response genes with pleiotropic physiological roles.

Authors:  Megan A Maxwell; George E O Muscat
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more
  48 in total

1.  Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Alexandra Lacey; Stephen Safe
Journal:  Mol Cancer Res       Date:  2019-08-28       Impact factor: 5.852

2.  NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.

Authors:  Erik Hedrick; Syng-Ook Lee; Ravi Doddapaneni; Mandip Singh; Stephen Safe
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

3.  Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma.

Authors:  Alexandra Lacey; Erik Hedrick; Yating Cheng; Kumaravel Mohankumar; Melanie Warren; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

4.  Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.

Authors:  Erik Hedrick; Xi Li; Yating Cheng; Alexandra Lacey; Kumaravel Mohankumar; Mahsa Zarei; Stephen Safe
Journal:  Breast Cancer Res Treat       Date:  2019-05-22       Impact factor: 4.872

5.  Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFβ-induced invasion of embryonal rhabdomyosarcoma cells.

Authors:  Rupesh Shrestha; Kumaravel Mohankumar; Stephen Safe
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

6.  Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.

Authors:  Kumaravel Mohankumar; Xi Li; Subhashree Sridharan; Keshav Karki; Stephen Safe
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482

7.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

8.  TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Stephen Safe
Journal:  Mol Cancer Res       Date:  2018-08-02       Impact factor: 5.852

9.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

Review 10.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.